Physician profile
Jonathan Patrick Behrens
NPI 1790214195
$13,442.62
in general payments reported to CMS, 2019-2025
7 companies · $521 in 2025
The $521 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,274 · 2021: $110 · 2022: $5,000 · 2023: $5,842 · 2024: $696 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Food and Beverage | $2,058.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,077.06 | 2022-2023 | Real Intelligence |
| Stryker Corporation | $1,863.70 | 2023-2025 | Mako, Triathlon |
| Elite Orthopedics, LLC | $1,274.00 | 2019 | |
| Medacta USA, INC. | $109.72 | 2021 | |
| Becton, Dickinson and Company | $78.01 | 2023 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $24.47 | 2025 | Zynrelef |
| Amgen INC. | $15.66 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Behrens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.